Registration Dossier

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
other: Assessment
Adequacy of study:
key study
Study period:
2019
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Assessment

Data source

Reference
Reference Type:
other: expert statement
Title:
Unnamed
Year:
2019
Report date:
2019

Materials and methods

Principles of method if other than guideline:
An assessment of the potential acute dermal toxicity of the substance was performed. An expert statement was provided.
GLP compliance:
no
Test type:
other: Assessment
Limit test:
no

Test material

Reference
Name:
Unnamed
Type:
Constituent
Test material form:
liquid: viscous

Results and discussion

Effect levels
Remarks on result:
other: not classified for acute dermal toxicity according to the CLP Regulation (EC) 1272/2008
Remarks:
(please refer to the supporting information attached)

Applicant's summary and conclusion

Interpretation of results:
other: not classified for acute dermal toxicity according to the CLP Regulation (EC) 1272/2008
Conclusions:
The substance is not considered acutely toxic by the dermal route based on an assessment.
Executive summary:

The acute dermal toxicity of the substance was evaluated in an assessment (attached).

The substance was not found to be acutely toxic by the dermal route. Details of the assessment are reported in the expert statement attached.